Back to Search
MARGARET ZAMBON, M.D.
M.D.
Pulmonary Disease Physician
NPI: 1609018613IndividualAccepts Medicare
Specialties, Licenses & Credentials
Critical Care Medicine (Internal Medicine) Physician
Internal Medicine — Critical Care Medicine
Code: 207RC0200X
265313(NY)
Pulmonary Disease PhysicianPrimary
Internal Medicine — Pulmonary Disease
Code: 207RP1001X
265313(NY)
Education
STATE UNIVERSITY OF NEW YORK AT BUFFALO SCHOOL OF MEDICINE
Class of 2009
Research & Publications (20)
Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season.
PMID 19331731·Emerg Infect Dis·2009
8-other
Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine.
PMID 19416838·Proc Natl Acad Sci U S A·2009
3-trial
A cell-based H7N1 split influenza virion vaccine confers protection in mouse and ferret challenge models.
PMID 19453487·Influenza Other Respir Viruses·2009
7-preclinical
A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine.
PMID 19368768·Vaccine·2009
3-trial
Start of the influenza season 2008-9 in Europe - increasing influenza activity moving from West to East dominated by A(H3N2).
PMID 19161722·Euro Surveill·2009
8-other
The immunogenicity of a cell-derived H7N1 split influenza virion vaccine in mice.
PMID 19439020·Scand J Immunol·2009
7-preclinical
DNA vaccination protects against an influenza challenge in a double-blind randomised placebo-controlled phase 1b clinical trial.
PMID 19368793·Vaccine·2009
3-trial
Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children.
PMID 19133796·Clin Infect Dis·2009
8-other
Personal protective equipment and risk for avian influenza (H7N3).
PMID 19116052·Emerg Infect Dis·2009
7-preclinical
Reducing perioperative myocardial infarction with anesthetic drugs and techniques.
PMID 19538174·Curr Drug Targets·2009
6-review
Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines--nonadjuvanted vaccine or vaccine adjuvanted with alum--given concomitantly with influenza vaccine to high-risk elderly individuals.
PMID 18855558·J Infect Dis·2008
3-trial
Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults.
PMID 18599164·Vaccine·2008
3-trial
Implementation of the Surviving Sepsis Campaign guidelines for severe sepsis and septic shock: we could go faster.
PMID 19056006·J Crit Care·2008
8-other
Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children.
PMID 18801398·Vaccine·2008
4-observational
Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe.
PMID 18445375·Euro Surveill·2008
8-other
Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants.
PMID 18514980·Vaccine·2008
7-preclinical
Public health implications of influenza B outbreaks in closed settings in the United Kingdom in the 2007/08 influenza season.
PMID 18801323·Euro Surveill·2008
8-other
Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1.
PMID 18843132·N Engl J Med·2008
8-other
Rapid quantitation of neuraminidase inhibitor drug resistance in influenza virus quasispecies.
PMID 18839782·Antivir Ther·2008
4-observational
Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans.
PMID 19033672·J Clin Invest·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1561 LONG POND RD STE 408
ROCHESTER, NY 14626 - Phone
- (585) 723-7575
Quick Facts
- NPI
- 1609018613
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 17
- Publications
- 20
Are you this provider?
Claim Your Profile